Serum interleukin-5 levels correlate with disease activity of ChurgStrauss syndrome in a patient treated with a leucotriene receptor antagonist, pranlukast, and inhaled corticosteroid

Scandinavian Journal of Rheumatology

Volumn 39, Issue 4, 2010, Pages 341-343

  Taki, H ^a   Shinoda, K ^a   Hounoki, H ^a   Ogawa, R ^a   Ishizawa, S ^a   Sugiyama, E ^a   Tobe, K ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; DNA ANTIBODY; EOSINOPHIL CATIONIC PROTEIN; FLUTICASONE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 5; NEUTROPHIL CYTOPLASMIC ANTIBODY; PRANLUKAST; PREDNISOLONE; RHEUMATOID FACTOR;

ADULT; ARTICLE; ASTHMA; CASE REPORT; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE ACTIVITY; DRUG WITHDRAWAL; EOSINOPHIL COUNT; EOSINOPHILIA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; RISK FACTOR;

ADULT; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; CHROMONES; CHURG-STRAUSS SYNDROME; DRUG THERAPY, COMBINATION; EOSINOPHIL CATIONIC PROTEIN; HUMANS; INTERLEUKIN-5; LEUKOTRIENE ANTAGONISTS; RECEPTORS, INTERLEUKIN-2; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77954876944     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009740903270573     Document Type: Article

References (16)

1. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL. Nomenclature of systemic vasculitis: proposal of an international consensus conference. Arthritis Rheum 1994;37:187-192
2. Masi AM, Hunder GG, Lie JT, Michel BA, Block DA, Arend WP. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angitis). Arthritis Rheum 1990;33:1094-1100
3. Sanderson CJ. In: Thomson A, editor. The cytokine handbook, 3rd edn. San Diego, CA: Academic Press, 1998:175-195
4. Tai P-C, Spry CJE, Peterson R, Venge P, Olsson L. Monoclonal antibodies distinguish between storage and secrete forms of eosi- nophil cationic protein. Nature 1984;309:182-184
5. Hellmich B, Csernok E, Gross WL. Proinflammatory cytokines and autoimmunity in Churg-Strauss syndrome. Ann N Y Acad Sci 2005;1051:121-131
6. Hayasaka T, Sasaki H, Sugawara T, Yasuura S, Kawamura T. Serum interleukin-2 receptor and interferon-7 levels in a patient with allergic granulomatous angiitis (Churg-Strauss). Intern Med 1992;31:955-959
7. Schmitt WH, Csemok E, Kobayashi S, Klinkenborg A, Reinhold- Keller E, Gross WL. Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage. Arthritis Rheum 1998;41:445-452
8. Morita H, Kihara T, Tatsumi Y, Kitano Y, Sagami S. Allergic granu- lomatosis and angiitis of Churg-Strauss. A case of high serum level of eosinophil cationic protein. Acta Derm Venereol 1992;72:201-202
9. Peen E, Hahn P, Lauwers G, Williams JRC. Churg-Strauss syndrome: localization of eosinophil major basic protein in damaged tissues. Arthritis Rheum 2000;43:897-900.
10. Ter Borg EJ, Horst G, LimbergnPC, Kallenberg CGM. Changes in plasma levels of interleukin-2 receptor in relation to disease exacerbations and levels of anti-dsDNA and complement in systemic lupus erytematosus. Clin Exp Immunol 1990;82:21-26
11. Schumitt WH, Heesen C, Csemok E, Rautmann A, Gross WL. Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosus: association with disease activity. Arthritis Rheum 1992;35:1088-1096
12. Nathani N, Little MA, Kunst H, Wilson D, Thickett DR. Churg- Strauss syndrome and leukotriene antagonist use: a respiratory perspective. Thorax 2008;63:883-888
13. Gleich GJ, Adolphson CR. The eosinophilic leukocyte: structure and function. Adv Immunol 1986;39:177-253.
14. Le Gall C, Pham S, Vignes S, Galcia G, Nunes H, Fichet D, et al. Inhaled corticosteroids and Churg-Strauss syndrome: a report of five cases. Eur Respir J 2000;15:978-981
15. Finkel T, Huntcr D, Paisley J, Finkel R, Larsen G. Drug-induced lupus in a child after treatment with zafirlukast (Accolate). J Allergy Clin Immunol 1999;103:533-534
16. Yoshida S, Ishizaki Y, Shoji T, Onomura K, Nakagawa H, Nakabayashi M, et al. Effect of pranlukast on bronchial inflammation in patients with asthma. Clin Exp Allergy 2000;30:1008-1014